1932

Abstract

Type I diabetes results from the autoimmune-mediated destruction of pancreatic beta (β) cells, which regulate blood sugar levels by secretion of insulin. Recent clinical data suggest that the disease could be cured if an adequate supply of new β-cells were available, and one goal of pancreatic developmental biology is to understand how endogenous β-cells are made, with the hope of making them exogenously. Much is now known about the transcriptional regulation of pancreatic organ specification, growth, and lineage allocation; less is known about intercellular signals that regulate this process, but candidates continue to emerge. Additional insights, often contradicting older models, have come from the application of new lineage-tracing techniques. Altogether, these studies also shed light on the still-elusive pancreatic stem cell, which may participate in normal organ maintenance as well as recovery from injury. A rigorous proof of the existence of such a cell, whether in vivo or in vitro, would offer real hope for the prospect of controlled β-cell generation in a clinical setting.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.cellbio.19.111301.144752
2003-11-01
2024-06-23
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.cellbio.19.111301.144752
Loading
/content/journals/10.1146/annurev.cellbio.19.111301.144752
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error